J. Montana

发表

Selecting Screening Candidates for Kinase and G Protein-Coupled Receptor Targets Using Neural Networks

Martyn G. Ford, David C. Whitley, Emanuela Gancia, 2002, J. Chem. Inf. Comput. Sci..

Selecting Screening Candidates for Kinase and G Protein‐Coupled Receptor Targets Using Neural Networks.

D. Manallack, D. Livingstone, W. Pitt, 2002 .

Estimation of pKa Using Semiempirical Molecular Orbital Methods. Part 1: Application to Phenols and Carboxylic Acids.

Emanuela Gancia, Benjamin G Tehan, David T. Manallack, 2002 .

Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.

D. Manallack, W. Pitt, J. Montana, 2001, Bioorganic & medicinal chemistry letters.

Aryl sulfonamides as selective PDE4 inhibitors.

J P Gregory, H. Dyke, J. Montana, 1998, Bioorganic & medicinal chemistry letters.

Aryl Sulfonamides as Selective PDE4 Inhibitors.

J. Montana, 1999 .

An enantioselective synthesis of sulphonamide hydroxamic acids as matrix metalloproteinase inhibitors

J. Montana, A. Baxter, D. Owen, 2002 .

A novel series of matrix metalloproteinase inhibitors for the treatment of inflammatory disorders

J. Montana, A. Baxter, J. Bird, 1997 .

PDE4 inhibitors: new xanthine analogues.

H. Dyke, J. Montana, N. Cooper, 1998, Bioorganic & medicinal chemistry letters.

Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.

M. Billah, R. Egan, H. Dyke, 2002, The Journal of pharmacology and experimental therapeutics.

A Novel Series of Matrix Metalloproteinase Inhibitors for the Treatment of Inflammatory Disorders.

J. Montana, A. Baxter, J. Bird, 1997 .

Design, Synthesis and Testing of Novel Inhibitors of Cell Adhesion

D. Manallack, J. Montana, R. Hubbard, 2000 .

The design, synthesis, and evaluation of novel conformationally rigid analogues of sialyl Lewisx

D. Manallack, J. Montana, R. Hubbard, 1998 .

Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: a new use of silicon bioisosteres in medicinal chemistry.

J. Montana, Louise M. Walsh, G. Showell, 2007, Bioorganic & medicinal chemistry letters.

5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitor.

J. Montana, C. Dix, H. Finch, 1998, Bioorganic & medicinal chemistry letters.

7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthma.

H. Dyke, J. Montana, J. Oxford, 2002, Bioorganic & medicinal chemistry letters.

The therapeutic potential of PDE4 inhibitors.

H. Dyke, J. Montana, John Gary Montana, 1999, Expert opinion on investigational drugs.

The synthesis of novel prostaglandin analogues via cycloaddition reactions

J. Montana, H. Finch, R. Taylor, 1990 .

8-Methoxyquinolines as PDE4 inhibitors.

H. Dyke, J. Montana, J. Oxford, 2002, Bioorganic & medicinal chemistry letters.

8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.

H. Dyke, J. Montana, J. Oxford, 2002, Bioorganic & medicinal chemistry letters.

Ketone homologation to produce α-methoxyketones: application to conduritol synthesis

J. Montana, M. Anson, R. Taylor, 1997 .

The synthesis of novel structural analogues of sialyl Lewisx

D. Manallack, J. Montana, R. Hubbard, 1998 .

α-Methoxyketone synthesis via ketone homologation: ZrCl4-mediated hydroxy sulfone rearrangements

J. Montana, R. Taylor, N. Phillipson, 1994 .

Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: a new use of silicon bioisosteres in medicinal chemistry.

J. Montana, G. Showell, M. J. Barnes, 2007, Bioorganic & medicinal chemistry letters.

Sila-venlafaxine, a Sila-Analogue of the Serotonin/Noradrenaline Reuptake Inhibitor Venlafaxine: Synthesis, Crystal Structure Analysis, and Pharmacological Characterization

J. Montana, R. Tacke, C. Burschka, 2006 .

(R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.

J. Montana, R. Tacke, G. Showell, 2006, Bioorganic & medicinal chemistry letters.

Synthesis, Crystal Structure Analysis, and Pharmacological Characterization of Disila-bexarotene, a Disila-Analogue of the RXR-Selective Retinoid Agonist Bexarotene

J. Montana, H. Gronemeyer, D. Ivanova, 2005 .

Silicon Analogues of the Nonpeptidic GnRH Antagonist AG‐045572: Syntheses, Crystal Structure Analyses, and Pharmacological Characterization

J. Montana, P. Muniandy, A. Hendrick, 2011, ChemMedChem.

The Synthesis of Novel Prostaglandin Analogues via Cycloaddition Reactions.

J. Montana, H. Finch, R. Taylor, 1990 .

Sulphone-mediated cyclobutanone to α-alkoxy-cyclopentanone ring expansion reactions ; scope, limitations and applications

J. Montana, A. Mjalli, H. Finch, 1990 .

D1927 and D2163

D. Manallack, J. Montana, R. Jackson, 2001 .

First isolation of Flexibacter psychrophilus, as causative agent of rainbow trout fry syndrome (RTFS), producing rainbow trout mortality in Chile

J. Montana, P. Bustos, B. Opazo, 1995 .

Use of polymer supported thiophenol for the synthesis and purification of a benzimidazol-2-one library

J. Montana, A. Baxter, S. Roberts, 2000 .

Glycosylation reactions of 2,3,4-tri-O-chlorosulfonyl-β-l-fucopyranosyl chloride and 2,3,4-tri-O-chlorosulfonyl-β-d-xylopyranosyl chloride

J. Montana, R. Hubbard, P. Murphy, 1996 .

Synthesis of (+/-)-Oxohexahydrofuro[3,2-b]pyrroles (Pyrrolidine-trans-lactones) via a Reduction-Alkylation Protocol

D. M. Buckley, J. Montana, S. Macdonald, 1998 .

Synthesis of (.+-.)-Oxohexahydrofuro[3,2-b]pyrroles (Pyrrolidine-trans-lactones) via a Reduction—Alkylation Protocol.

D. M. Buckley, J. Montana, S. Macdonald, 1999 .

Update on the therapeutic potential of PDE4 inhibitors

H. Dyke, J. Montana, 2002, Expert opinion on investigational drugs.

Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.

J. Montana, R. Naylor, J. Rudd, 2008, Toxicology and applied pharmacology.

Lymphoma of the thyroid mimicking thyroiditis in a patient with the acquired immune deficiency syndrome

J. Montana, L. Poretsky, B. Piper, 1994, Journal of endocrinological investigation.

Current and Emerging Therapies in Chronic Obstructive Pulmonary Disease

N. C. Ray, H. Dyke, J. Montana, 2010, Burger's Medicinal Chemistry and Drug Discovery.

7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma.

J. C. Gregory, H. Dyke, J. Montana, 2000, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors.

H. Dyke, J. Montana, N. Cooper, 2001, Bioorganic & medicinal chemistry letters.

Section Reviews: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthnlis: New therapeutic approaches to atopic dermatitis

J. Montana, J. Bird, 1996 .

Synthesis and profile of SCH351591, a novel PDE4 inhibitor.

H. Dyke, J. Montana, J. Oxford, 2002, Bioorganic & Medicinal Chemistry Letters.

Bromobenzofurans : a new class of potent, non-peptide antagonists of angiotensin II

J. Montana, K. Clark, M. J. Robertson, 1991 .

Chapter 5. Phosphodiesterase 4 inhibitors

H. Dyke, J. Montana, 2001 .

D1927 and D2163: Novel Mercaptoamide Inhibitors of Matrix Metalloproteinases

D. Manallack, J. Montana, R. Jackson, 2000 .

Synthesis, crystal structure analysis, and pharmacological characterization of desmethoxy-sila-venlafaxine, a derivative of the serotonin/noradrenaline reuptake inhibitor sila-venlafaxine

J. Montana, R. Tacke, C. Burschka, 2006 .

Theoretical hydrogen bonding parameters for drug design.

D. Manallack, E. Gancia, J. Montana, 2001, Journal of molecular graphics & modelling.

Synthesis of trans-fused [5,5] bicyclic lactones/lactams as templates for serine protease inhibition

J. Montana, H. Finch, H. A. Kelly, 1998 .

Mercaptoacyl matrix metalloproteinase inhibitors: The effect of substitution at the mercaptoacyl moiety

D. Manallack, J. Montana, S. Neidle, 1997 .

Amino acid derived thiane oxide and dioxide systems as disposable templates: Synthesis of α-amino ketones, anti-amino alcohols and an amino cyclopentenone

J. Montana, P. O’Brien, G. Giblin, 1996 .

Amino Acid Derived Thiane Oxide and Dioxide Systems as Disposable Templates: Synthesis of α-Amino Ketones, anti-Amino Alcohols and an Amino Cyclopentenone.

J. Montana, P. O’Brien, G. Giblin, 1997 .

Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma.

J. Montana, N. Cooper, P. Hellewell, 1998, Bioorganic & medicinal chemistry letters.

Benzofuran based angiotensin II antagonists related to GR117289: enhancement of potency in vitro and oral activity

J. Montana, K. Clark, M. J. Robertson, 1993 .